A9545 Iodine i-131 tositumomab, therapeutic, per treatment dose

Short descriptor: I131 tositumomab, rx

⚠ Terminated HCPCS Level II 2026
Terminated Code
A9545 was terminated as of 2016-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open A9545 in the app →

Look up A9545 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

A9545 is the HCPCS Level II code for Iodine i-131 tositumomab, therapeutic, per treatment dose (2026). It belongs to Section A — Transportation, Medical & Surgical Supplies. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Other carrier priced.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Other carrier priced (indicator 57)
Type of Service
Therapeutic radiology
Effective Date
2017-01-01
Termination Date
2016-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference A9545 with the canonical source and edition:

A9545 — Iodine i-131 tositumomab, therapeutic, per treatment dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/A9545

Canonical URL: https://icd10codingpro.com/hcpcs-codes/A9545

Related Codes in Section A

← A9544 I131 tositumomab, dx A9546 → Co57/58
A9541 Tc99m sulfur colloid A9542 In111 ibritumomab, dx A9543 Y90 ibritumomab, rx A9544 I131 tositumomab, dx A9546 Co57/58 A9547 In111 oxyquinoline A9548 In111 pentetate A9550 Tc99m gluceptate A9551 Tc99m succimer A9552 F18 fdg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial